You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

7 Results
Guidelines and Advice
Status: Archived
ID: 5-3
Dec 2009
Guidelines and Advice
Status: Archived
ID: CED 14-2
Oct 2009
Guidelines and Advice
Status: Archived
ID: CED 14-1
Sep 2009
Guidelines and Advice
Status: Archived
ID: CED 13
Jun 2009
Guidelines and Advice
Status: Archived
ID: CED 12
Apr 2009
Drug
Other Name(s): Mekinist®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2025
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trametinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025